- Home
- LUNR vs ELVN Comparison
LUNR vs ELVN Comparison
Compare LUNR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- ELVN
- Stock Information
- Founded
- LUNR 2013
- ELVN 2016
- Country
- LUNR United States
- ELVN United States
- Employees
- LUNR N/A
- ELVN N/A
- Industry
- LUNR Industrial Machinery/Components
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- LUNR Industrials
- ELVN Health Care
- Exchange
- LUNR Nasdaq
- ELVN Nasdaq
- Market Cap
- LUNR 1.3B
- ELVN 1.2B
- IPO Year
- LUNR N/A
- ELVN 2020
- Fundamental
- Price
- LUNR $8.77
- ELVN $20.27
- Analyst Decision
- LUNR Buy
- ELVN Strong Buy
- Analyst Count
- LUNR 7
- ELVN 5
- Target Price
- LUNR $13.71
- ELVN $41.20
- AVG Volume (30 Days)
- LUNR 8.4M
- ELVN 424.2K
- Earning Date
- LUNR 08-07-2025
- ELVN 08-13-2025
- Dividend Yield
- LUNR N/A
- ELVN N/A
- EPS Growth
- LUNR N/A
- ELVN N/A
- EPS
- LUNR N/A
- ELVN N/A
- Revenue
- LUNR $225,977,000.00
- ELVN N/A
- Revenue This Year
- LUNR $13.95
- ELVN N/A
- Revenue Next Year
- LUNR $47.98
- ELVN $25.00
- P/E Ratio
- LUNR N/A
- ELVN N/A
- Revenue Growth
- LUNR 42.86
- ELVN N/A
- 52 Week Low
- LUNR $4.72
- ELVN $13.30
- 52 Week High
- LUNR $24.95
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- LUNR 36.68
- ELVN 51.83
- Support Level
- LUNR $8.30
- ELVN $19.30
- Resistance Level
- LUNR $9.12
- ELVN $21.14
- Average True Range (ATR)
- LUNR 0.43
- ELVN 1.18
- MACD
- LUNR -0.01
- ELVN 0.16
- Stochastic Oscillator
- LUNR 19.26
- ELVN 65.64
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.